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left venbicnlar assist device bas 
a%ridge~tocan%actrans@atation.Altltougb 
therearereportsdocMlentlngltsclrclda~snpport,liikis 
ltmmt8bontthe~ofcbronlcleftvfntricularMlmdh3gon 
tltelx!artitself. 
Cardiac transplantation has become a widely accepted treat- 
ment for end-stage heart disease. However, the demand for 
donor hearts is much higher than the supply (l-3), and many 
patients dii while awaiting transplkutation. Thus, the leti 
ventricular assist device has been important as a “bridge” to 
eardii transplantation (4-6). and a variety of devices have 
been used for this purpose (4-9). There have ken several 
reports regarding hemodynamic or peripheral organ responses 
to the ventricular assist device (4,5,8,10). However, little is 
Resok Left atrial aad left ventriadar diastotic and systok 
diameters decreased immcdiiteiy after iasertion of the left ven- 
tricular assist device (from 46 to 3563 to 41 aad 59 to 36 mm, 
respectively, all p c 0.001). Left ventricahr wall tbickaess ia- 
creased from 10 to 14 mm (p C 0.001) for tbe iatcrveatriadar 
~mapd~1Oto13~forthe~~orwall(pco.~1). 
No -ihic nwasumments showed sigaifnnt subse- 
pent cbaages at the chronic stage. Myocardiat histologic thlings 
demon&atedarede&minmywytedxaage((brotsl.9toO.5,p< 
0.901, for wavy fiber and froan 13 to 6.2, p < 0.01, for coatractioa 
band necrosis) aad aa h-ease in fibrosis (from 13 to 1.9, p < 
&tE), hmt w%tottt s~llt change in t3yocyte diimeter (lhm 
15.6to16.8yp5p=0.065). 
(J.&II COB Cm&d 199@27:894-WI) 
known about the impact of the device on the left ventricle 
itself. The left ventricu%r as& device provides remarkable 
unloading to the ventricle, and the aortic valve typically does 
not even open during function of the device (8). Therefore, 
some changes may be induced in the left ventricular structure 
and histology (11). Because some forms of heart failure are 
potentially reversible, it is important to detenine the effect of 
long-term ventricular unloading on the left ventricular struc- 
ture and histow. 
The HeartMate (lOOOlP, Thermo Cardiosystems Inc.) is an 
implanted left ventricular assist device. It has been reported to 
provide consistent hemodynamic support with sustained reduc- 
tion in both left ventricular preioad and afterload without 
serious adverse effects (5,6,8,12). In the present study, echo- 
cardiographk observations were done b patients before and 
after Hear&fate insertion to determine the effext of ventricu- 
lar unloading on the left ventricular structure. In addition, to 
determine the impact on myocardii microstntcture, histologic 
examhlatioos were performed in left veotrielth r.pecbens 
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oblGned before ventricular assist device insertion and at the 
time of expbuttation and subsequent cardiac transplantation. 
Ms?thods 
Study patknta. Nineteen patients with end-stage heart 
failure who umktwent HeartMate left ventricular awist device 
insertion as a “bridge” to cardiac transplantation were studied 
(17 men, 2 women; 35 to 62 years old, mean age (tSD] 50 % 
8; idiopathic dilated cardiomyopathy in 7, iscbemic cardiomy- 
opathy in 12). Despite inotropic (19 patients), ventilatory (14 
patients) and intraaortic balloon pump (16 patients) support, 
mean cardiac index was 1.60 z 0.27 liters/min per m2 (range 
1.17 to 2.05) at assist device insertion. 
HeartMate device. Tbe HeartMate lOOSIP device is an 
implantable, pneumaticaIly driven, pusher-plate type pump 
($6.8). The pump housing is placed in the patieru’$ leti upper 
abdominal wall, and the pneumatic drive line is connected to 
an external console. A plug of the left ventricular apex is cored, 
and the inSow cannula is inserted into the apex The outSow 
25mm Dacron grab is anastomosed to the proximal ascendmg 
aorta. Porcine biiprostbetic valves are used for both it&w and 
outfkw conduits. Blood drains from the left ventricle through 
the in&v valved conduit into the pump by a pressure differ- 
ence between the left ventrick and the pump and then is 
ejected througb the outflow conduit into tbe ascending aorta. 
The maximal stroke volume of tbe pump is 85 ml with a 
maximal fIow of - 11 titers/mitt (5,6,8). The pump is driven in 
either a &d-rate (adjustable beats/mm) or an automatic 
mode. In the automatic mode, the pusher-plate automaticaby 
ejects when the pump chamber is 90% filled, allowing naturaI 
adjustments in cardiac output to the physical demand. The 
device was typically driven in tbe automatic mode &ortIy after 
weaniogfromcardiopulmonarybypassduringthebtireperiod 
of ventricular assist, achieving signiticaot unloading of the 
beart until expkntation and cardiac transpkntation. At the 
time of ortbotopic cardiac transplantation, recipient cardkc- 
tomy and pump removal were performed. The. left ventricubu 
apical core from the time of insertion and the explanted 
recipient beart were availabk for patbologk examination and 
histologic comparison. 
Imraoperative traosesopbageal echo 
car rmed at HeartMate iosertion and at its 
expkntation and subsequent beart tra.nsplantation with a 
cmmerciaUy available echocardiograpbic system (Hewlett- 
PadrardSonosORandSonos15OO)orAcuson12SXP.All 
imageswerere4mrdedonO.5-m.VH!SvicWapeandwere 
reviewed ntroqxdw$ for evahmtion of walI motion and 
chamber measurements using nuodimeusional and M-mode 
modal&s (13,14). The presence of sortie regmgbation was 
asi%medbycoiorDoppIerecbocardiograpbyM-t5 
iitchdedl kft atrial mc diameter, mea&ed between tbe 
aDdauiaIseptuminthebeselfour- 
view;I~tvlee&rdirstolicmKlsystolic 
diametera sod dkstohc interventriadar sep~I tb&tess and 
kftvetl~pw~~eithertrans- 
gastricdy or basally. Fractional shortening of the left ventride 
was calculated as 
Fractional shortening tci; t = [(Dd - D&&t] Y 100. 
where Dd and Ds are left ventricular diastolic and systolic 
diameters, respectively. Anatomic landnlarks (papillary mus- 
cle, aortic and mitral valves) were used to ensure that mea- 
surements were made at the same left ventricular or atrial 
level. Measured data were divided into three groups according 
to the time of observation. as folkws: 1) before cardiopubno- 
nary bypass, at the time of left ventricular assist device 
insertion (baseline stage j; 2) immediateIy after insertioo, when 
the hemodynamic variables were stable (after pump stage); 
and 3) just before assist device explantation and subsequent 
heart transplantation (chronic stage). 
Histologic examiaatimr. To determine the histologic 
changes that accompanied these ventricolar structural changes. 
myocardiil specimens from 14 patients who succe&ully un- 
derwent cardiac tran.spIantation (mean duration of kfi ventric- 
ular assist device support 73 days) and 1 patient who died from 
fungal sepsis after 70 days of support were studied. M the 15 
patients studied, 6 had diited cardiomyopathy, and 9 had 
iscbemic cardiiopatby. ‘IAe left ventricular myocardial 
specimens were ohtaii from the cored kti ventricukr apex 
atthetimeofiarertion(meanvdume5.8~43cm3,range 
from15XOgX0.5to4Jx3.5X1.0cm)andfromtheIeft 
vemrick of the expbmted beart at the time of trampkntation 
(mean weight 489 It 75 g). These samples were fixed in 
buffered formalin, emhe&kd in paraffin, cut in 4-m sections 
and stained with hematoxybn and eosin. Doe section from each 
of the insertiott and explantation specimens was examined 
histo@cally. Sections exam&d from the left ventrick of the 
explanted heart x.ere chosen from areas adjacent to tbe ep4 
far enough away from the in&w carmula to avoid SecondrzIy 
bistoIogiccbangestbatmigIttbeasEociatedwitbtbecaMuIa 
itself. Because b&oIogk assessment w-as performed retrospec- 
tiveIy,apicaltissuewasootalway5availahk.Theexamination 
incI& qualitative (0 to 3 scak) -ntofwavyfibers, 
contraction band necmsisand#rosisasameasureofmyo 
cardiaIinjuty.Featuresweregra&duO=absen~1=mild 
(findiogsoccupkI<lO%oftbetisaiesampk);2=moderak 
(fbldmgsoccupkdfromlO%to3O%oftbetimuesampte):and 
3 = prominent (ii&ings oca@ed >30%) (15). ‘Ihe pmsence 
orabsenseofaa.ltempcarttial llecmGswasatsalx%edAcute 
nec-osbandIIbr&areb&ologicfe.aturestbateao 
~~ibothduatedandiscbemicardamJopa~. 
WaVyIIbeNaadlantradionbpad nefmsirarefeaturest&atiue 
indkativeofmyoatdialatia.Tbe~d~6heN 
aodcootractioa~necnosiswaacvahutedinaIlpaticntsto 
assessthepresenaofaalteitcbemic~Inodrlitim, 
minimaI~diameteraauE.sthemlcleuswas~ 
at a tionof1?OalxusiogtbeRioquantsystem 
(W.Nwhsbat~,Iuc.)cmtmUed~a~comprter 
(Gateway 4DX-66IJ, Ciateway) (16). An average of 100 mp 
lyeswerealla&dperseuion. 
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Table 1. Changes in Eclwcardiographic Measurements 
After Pump 
stap 
(n = I?) 
chronic stage 
(D = 16) 
liters/min per m2 (p < 0.05) after left ventricular assist device 
insertion. Duration of support ranged from 3 to 153 days 
(mean 68 2 33). 0ne patient died of multiple organ failure 3 
days after device insertion and two patients of fungal sepsis 
after 44 and 70 days of support, respectively. Sixteen patients 
underwent orthotopic cardiac transplantation after 22 to 153 
days of support (mean 66 2 31). 
‘p < Da01 versus has&e stage. Data presented are mean value + SD. 
W = left ve~b-kttlar diiolic diameter: Ix = left ventricular systolic diameter; 
FS = pemt hactkml shortening; IVST = intelventricular sqtal thickness: 
LAD = left atrial systolic diameter; PW = left ventricular pastenor wall 
thicknm. 
Statistfenl analysis. Results are expressed as mean value t 
SD. Comparison of differences among the three stages was 
done with analysii of variance and the Bonferroni r test. 
Comparison of wall thickness changes between akinetic and 
other segments and comparison of histologic indexe: between 
dilated and ischemic cardiomyopathy were done with unpaired 
I testing. Least-squares linear regression analysii war used to 
correlate wall thickness with left ventricular dianreter. To 
assess the cause of left ventricular assist device-induced in- 
crease in wall thiikness, we developed a matnematical model 
quantifying the change in wall thickness required to preserve 
wall mass as cavity diameter changes in a thick-walled spherical 
shell (see Appendkx). The predicted slope of the diameter 
(D)-thickness (T) relation (dT/dDj was compared with ob- 
served changes in patients. Results were considered significant 
at p < 0.05. 
Mean cardiac index 
- 0.27 to 2.99 t 0.40 
F&oeardiogntphic Ladings. Because we reviewed tapes 
retrospectively, some suboptimal recordings were excluded 
from the analysis. Thus, data from 19 patients (7 with dilated 
cardiomyopathy, 12 with ischemic cardiomyopathy) served as 
the baseline data; data from 14 (7 with dilated cardiomyopathy, 
7 with ischemic cardiomyopathy) served as the after-pump 
data; and data from all 16 (6 with dilated cardiomyopathy, 10 
with ischemic cardiomyopathy) who had cardiac transplanta- 
tion served as the chronic stage data. 
As shown in Table 1, before HeartMate insertion, left atrial 
and ventricular dilation and thin ventricular walls were found 
in all patients except two who had an acute myocardml 
infarction and normal diastolic ventricular diameter. After 
insertion, the aortic valve did not open in any patient, demoa- 
strating significant left ventricular atierload reduction. Mild to 
moderate aortic regurgitation was seen in two patients, and 
ventricular preload reduction was considered to be incomplete 
in these patients. Figure 1 shows representative ezhocardio- 
graphic observations before and after the assist device inser- 
tion. With left ventricular assist device insertion, left atrial 
syctolic diameter decreased from 46 % 6 to 35 2 5 mm, left 
ventricular diastolic diameter from 63 ? 15 to 41 + 9 mm, and 
systolic diameter from 59 C 15 to 36 -C 9 mm, all highly 
significant (p -C 0.001). Wag thickness increased signifRantiy 
from 10 2 2 to 14 + 2 mm for interventricular septal thickness 
and from 10 -+ 2 to 13 2 2 mm for posterior wall thickness (p < 
O.uOl). At the chronic stage, chamber size and wall thickness 
showed no significant changes from those obtained after pump 
stage. 
I F&e 1. Left ventricular morphologic changes try tet-t ventricular assist device insertion observed by tram- esophageal emocardiography. UPm I#met& Basal 
fotlr-cItambet trartsesopbageal vies% before Qetlt arld 
after sup@ @i&t). Lams pads, Tram+& short- 
axi5viembefmi.leR)and&ersupport(ripti). 
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Fi 2. Changes of leti ventricular diastolic diameter (Dd) and 
mean wall thiikness of intecventrisslar septum and posterior wall 
[(IVSr + EWT)/2] before and icxxdiateiy after as& devise inser- 
tion.kn3ws=intrwperativechangeofeachpointffomtiprepimp 
(baseline) to the postpump stage. LX34 = dilated cardiomyqwhy; 
X34 = ischemic cardiimyapathy. 
When the baseline data of wall thicknesses were compared 
with the data at the left ventricular assist device explantation 
(chronic stage), akinctic or dyskinetic walk demonstrated ks 
increase in diastolic wall thickness (mean change 1 t 1 mm, six 
segments [four from patients with dilated -thy, and 
two from patients with ischemic cardicqq&y]) than those 
with any degree of contrxti.lity (mean change 4 5 2 mm, 19 
segments [7 from patients with dilated cardioqopatby, 12 
from patients with ischemic cardiiyopathy], p < 0.001). 
Figure 2 shows the relation between left ventricular diastolic 
diameter and mean wall thkknes obtained as an average of 
septal and posterior wall thickness before and after pump in 
12 patients with complete data on both the dim-+x&on and wall 
thicb. There was a significant negative correlation between 
these variables, irreqective of the etiology of the disease (r = 
-0.73, p < 0.001, F% 2). Average kft ventrkular diastolii 
diameterinthesel?,patkntsdecreasedfrom60to41mmaad 
mean wail thickness increased from 10 to 14 mm. Thus, tbe 
average increase of wail thickness was 0.21 mm/l-mm decrease 
in diastolic diameter. This tinding was simiiar tc the prediied 
value of 0.21 mm predidtd for a thick-walled sphere (see 
Appendix), demonstrating that most of the change in wail 
thickness was explained by -n&on of mass rather than by 
any fundanmtal change in ceilular size. Frxtional &rteaing 
did not shuw significant changes before and after left ventric- 
ular assist device insertion. 
- Flolidchangcsdacutcnyocardi 
necrosis were in 7 of 15 patktits (2 with d&ted 
car~tby, S with isehemic cardiomyopathy) at the time 
of insertion but in none at explantation. Iaspec+x d myocar- 
dial tissue from left ventricular assist d&x btsertiun revealed 
prevaknt wavy fibers and asntraction band namsisinbuth 
dilated and isdmnie e (Tabk 2). After cJ3ronic 
baeadarsltpport,shcrewasasjgnibcaatdecrrascinrgt 
eardialinjutywitha t-inscwesdbothotbwavy 
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Tat& 2. Histdogk Features at Insertion and &plantation oi L& 
Ventricular Asii Device 
fibers aod c-lxltractioIl ?md ll43msis (from 1.9 10 0.5. p c 
0.001, for wavy fiber md Iii 13 to 02. p < 0.01, for 
contraction band nea~is) (Fig. 3). When dilated cardii 
a&y was compared wth ischemic cardiomyopathy, no sign& 
cant ddIemtrx was found in any bariabk at eithex insertion or 
explantatien (Tab&e 2). There was also no signilicmt diScrena 
in the deaease in wavy fiber (mean change -1.7 2 OS for 
dilated cardiomyapathy, - I3 I 0.7 for ixbemic cardiomyq 
athy,p=0341)andlx&ra&mbandoeaosis (=drulbe 
-0.7 f 1.0 for ditated cardiaappachy, -13 2 13 for 
iszhcmic e, p = 0310) between two gtqs. Ibe 
~fibrosisswreinaeasedpatttyrctkctinghealingdacute 
mpcanid rtrxmis (from 13 to 1.9, p < 0.05). AltbmJgh 
myccytediameteracrosTthcnudeustendedto&reaseaftcr 
duonicsuppor&itdidnotreachstatistial asa 
WlKrk (15.6 vs. 16.8 jlm. p = 0.065) (Table 
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aaualmyoeytediameterarromthenudeusdidnotincrease 
Sig4i~tlyafterkftventrieularassiftdevicesupport(wrmal 
myqte diiter 10 to 15 p) (1% suggesting that myoqte 
hypertrophy was not a cur% of the increase in wall thiikness 
hut rather geometric rearrangement of the tissue with reduc- 
tion in chamber size. lndex$ mathematical modeling demon- 
strated that most of the increase in wag thickness cau be simply 
expbined hy amservation of mass as the chamber diameter 
de-xreases (see AppJendiu). 
Ike have heea several prior repurts showing vofume- 
indud changes in ventriadar wall thidmes clinifauy (18) 
and experimentally (19.20) that have similariy demonstrated 
an inverse relation between wall thickss and ventricular 
lmhlmeeoosistentwithmassc4HtservatimL1nanexvivorat 
model for example, it was demonstrated that internal re- 
almgement of the vewriallar wan fibers or side to side 
slippageofmyoqes4edtoan &ease in wag thidoress with 
the cleavage plane between fiber bundles becoming oriented 
hwrea+& perpendicular to the endocardii surface as the 
walfthkkned(19).Tksamemecbaniiisappiiedtoexplam 
ventrkulardilationandwaUthimringinthenoninfarcted 
(21J2) or vent&& retIlo&rg 
(23). Examination of cardiomy* 
~hearts6xedatvaryingdegreesofdiionmighthelp 
tochifythenle4bnhofthewanthicbeniag. 
Ven~wansindilatedandiscbemifcardiomyqwthia . . 
are~thinandhypocootraailewithonfysligbt 
insytole,Littleisknownahoutwbetherthis 
isretwaetotipointofreuwe~normal 
lnthepreserltstudy,weshowe4lthatthin 
cardiomyopsthiewaUscouldthicken(atfeastpassivefy)iftlrey 
~tmydegreeofamtmct%ty.inumtraa,myoEardiumthat 
aascollsideredDomiaMe(thinned,akine~andhyperedtoic) 
Seemed incapgMe of inWas@ its thiclrnem at aff. According 
totltemechamamofvnlume-indneeddtangeinwauthickness 
assist device insertion, which was recorded using a 5F 
micromanometer-tipped catheter (Millar Mihro-Tip model 
SK751, Millar Instruments) inserted from the right pulmo- 
nary vein. Left ventricular systolic presume decreased to 
-40 mm Hg after insertion. The triad :,i increased wall 
thickness, decreased chamber size and decrease in intracavi- 
tary pressure all led to a dramatic reduction in left ventricular 
w-all stress, “resting” the myueardium, which may be of value in 
occasional patienr~ 4th reverst&le cardiithies. 
E&CtOfWabiCl?~SrkladhSgoplenV~triete 
e&y. l%e effea of chronic unloading on myoqte structure and 
functiouisltlbownbccauseoffewprevious studies. In the 
current study, analysis of myocardial histologic find@ dem- 
onstrated a reduction in myocyte damage after a mean of 73 
days of ventricular unloadmg irmspeftive of t!re etiology of the 
disease. Acute myocxdbl necrosis, observed at device inser- 
tion in patients with both ischemic and dilated eardiimyopa- 
thy, was accompanied by both wavy fibers and cnntraction band 
Fw 4. Left veutricuk pressure tracings kfore (tep) and after 
) kft ventricular assist device insertion 
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iJUXOSk l%iS tiding suggests the fJfesenCe Of acIlk? WoCar- 
dial ixhetnia in both patient groups. The iscbemii changes in 
patients with dilated cardiomyopathy may be caused by tow 
ihxv states in the pericd imruediatety before device insertion. 
This is in agreement with a prior ltii report of patients 
wilb left ventricular assist device implantatiolJ, which sug- 
gusted that myocan%i injury was redttced after suppcul(l1). 
However, io contrast, near-complete unbadii of the ventrick 
witbaventrRtdarassistdericehasbeenrepmtedtoinduce 
severe atrophy of the myocytes in experimental animals 
(2425). ‘ho fktors may help explain this apparent diiep 
aocyz 1) IO our study, the left veotricular assist device was 
maiotainedirJtheautomaticmode,eoablingtlJeveotrideto 
amtractagainstalowafterioad,yetstiRproducingabw 
intrav~triadar vjstoiii pressure (Pii 4). Thib incnmpfete 
uoloadiog may help prevent the myoqtes from becoming 
atrophic. Thus, prapcr “resting~ with incmnpiete unfoading 
maybene4xxaqforthenxweryoftbeveotrjadarmyocar- 
diumltist~andtoavajdmyocyteatrcphy.Apreviuus 
reportdemmMratingt.heimportanceofloadingiureversittR 
JJlpXdiiatrophyiMIdbyunioddiogsuppoItSthiS(26),~ 
dOL?Stkantcordancebe~Othehbtologic~dthiS 
study and prevbus ones (1129). 2) Auutkr reason for this 
dislqaqolaybethe-ddisease.ourpatie.JJtsan 
haded4ageheattfaihJ~frotoidkrpathicorisdJemiicar~ 
oyopaay,whereastheexperimeotalaoiomisbadoomyocar- 
dialrlkease(24~)andmaybavebeenatuKreamd*for 
dislJseatJnpby.oreraIlhowever,these.apparenuydkarntant 
datapointupthenecdformorcbasiiitweSi@tiunoftlds 
Jssue. 
Tbe histologic studies are limited by the small sample 
number. The data may also be affected by tlte fact that the 
iopbJJtationsamplecaolefronJanapicaluuesaglpk,whidJ 
utayhaveagreatertendnmytoitave6brosisaudirhcmic 
lnthepreseotshJdy,weshowedthal 
thittwaRsinca&qopathybecamethickerafteriusettinnd 
akftveotriadarassktdevioeinas5ociationwitbadramatic 
redu&onindnuubervoltune.TtdsfiudingmaysuRgestdtat 
wallthimtiqincanfiwpprthyispart!yarnsuitufloadtng 
a~andmayberevemedbyappopiatelosd- 
therapy. Because mass conservation ddates some increase in 
waR~ourotucrvationdoestmt~iiadiate 
myocdiai viability. Hm. tbefacfthatwausthatwere 
iBMith?dwmiabte(~d)sborved 
k!SStiJiiklJiJJg~sOmereliraiomhipbetveeOtherwwS 
iqilitlrdwautbiiaodmpcarrlialvirbility.side~ 
slapp&e~~outyMumaurheotbem)mrd*ms 
tt . pragrsses and ~~~~~~ 
tThJSiS(27).AppoprietelOCidrebctiostherapyifil 
beQoredmlopneuld6hNnis?olaydelay~d 
wiiustles%msbitPpporud 
damagvrtcdhere. 
an a&t device. Left ventricular improvement could not be 
espe&d in completely infarcted areas, txcau~ rnyoqtes 
cannot regenerate once they die. Therefore, one might expect 
true recovery only in the borderline areas of isfkmia and 
edema, which may be salvaged. Traditionaliy. the left ventric- 
tdarassistdmicehaskenutilizeda5a~”tocardi;r 
transplantation. However, if snrne tin&mat reciweq were 
observed with the veturicub assist device. some cases mig’tt 
be weaned from a ~~ntt-icuiar wrppocl. particulariy dxnx with 
myocarditis. as was &own in a preyious report (28). Reazndy. 
thres patients were weaned from the Ncwacnr left ventilar 
assist device after several months of support (Former P. 
OaklandcalifomiapeMcni b May 19%). This 
sagge?athefeasibilitrdleftven~~devieessm.iJJg 
nutcadyasa%ridf$totram+ntattoatnrtalsoasatmatmem 
d certain types d hea~3 failure. Moreover. a recznt report lw 
Frazier (29) of the 6.rst IJYZ of a vented ektrk Heat-Mate 
zstron&suggestthatieftventriarkrassistdevicesmay~ 
cardiac fundon. Gnu&em with our present resul4 he 
sbmved~tdvfflaieulvanfiguntionaodmyucar- 
dialhistdoeyinapatientwithidiithicdii‘bdcardbmyop 
athyafteriong-temtsuppmt.Attlmt@tkpatientdiedfroma 
ueurob+e-ventafter503daysofsuppotthisbeartshmd 
iJtcmdejodioofractioaanddcaeavdleftveotrinJlardir- 
stdicdiameterandcudd llmdain siradatioil without vJ!s* 
premorsqqhntewnafterthedeviorsupfmttwasdiscontio+ 
uedeecuisethe~forcwdit?etramplurtationfar 
escee&tueaurentdwasupply(l-3).~icat~~ 
wMriatlarassistdeviccasatreatmem 
myopalbiesJoaykwananted.However.vcslJoddcuehdiy 
aaasthepossiiityofrermwaloftheaGstdcviceinpaticn&. 
llecamewhetbersauctunlandhistcdogicdrangesn*lldbe 
sustainedafternmovalisuntglnsaskbIle~-ttw 
f3fOp&FUR&XcItemivestudig~aeedcdOOtkiS~. 
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mean of 68 days in our patients Therefore, we could no! 
predict the amsequenoes of a longer period of support. ooc 
report with three cases showed ventriadar wall thinning after 
long-term implantation (6 to 12 weeks) with a left ventricular 
assist device (ll), which may suggest that more prolonged 
z amif resdt in Merent sequelae t@t might (or might 
~tutheleftventricle.Thu.sifitispsiile 
for some patients to be weaned Gom the left ventricular assist 
device, detemkiaation of the optimal duration of support 
shoukiheanaimoffutnreshdks. 
CO&&M. Cbrrmic ventricular unloading with an im- 
plantable left ventricular assist device signilicantly reduced left 
attial and ventricular size, with an increw in wall thickness, 
there@ deaeasiog wall stress. Myocardial histology demon- 
&rated a reduction in myocyle damage. Thus, the left ventric- 
ular tesist device may have a role in ‘&sting” the ventricle in 
selected patients with heart failure. 
Appendix 
Volume-lndrcced Changes in Lej? Ventricular 
wan ivlicw 
We hyphe&A that the increase in left ventricular wall 
thiekms iuduced hy veutriatlar voIume deaeasc can be 
-?llathematicaIIy. 
tSetv%g fer tIdeIt* spherid mndet. If the left ventri- 
cIe can he assumed to he a thick-shelid sphere with an 
internal diameter of D and waII thidmes of T, then I& 
ventricular mass M can bc obtained as follw: 
= pu/qfiDT f 12DT~ + ET?), 
winxep=myocwd@demity.LeftvenbiasIarmassisthusa 
fur&on of D and T [M(D, T)] and may vary with independent 
changs iu either of these variables, aIb$/aD and ahi/JT. Left 
verttricbr mass does not change simpIv by changing chamber 
vohme. lkrefore, 
dbl = 0 = (dM/aD) dD t (abt/i~T) dT 
* pn@(12M + Irr) dD + (SD’ + 24DT + 24T’) ar) 
SoIviug this equatiou for dT/dD, 
dI7dD = - W-f + ZI”)YD’ + 4DT + 4T’). 
By dividing both numerator and denominator by d and 
=PfotcgllrT~byc, 
mdD = - (2 + 2&I + 46 t 48,. 
kmnting to the data in Table 1, the baseline E is -0.16 
(=ioHi3). -Illus, 
lrr/dD= -021. 
TBismeansthatwhendiast&cdimcusiondareases lfM&Lft 
venrricularwatItbicbssinueases 0.21 mm. This vahlc is 
abostidentbItotheaUuaIchangesbownbythepresent 
-JY 0%. 2). 
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